| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000028238 |
| Receipt No. | R000032320 |
| Official scientific title of the study | A study on effect of salt-marinated rice malt (shio koji) on fasting blood glucose level : A randomized, double blinded, placebo controlled study |
| Date of disclosure of the study information | 2018/11/03 |
| Last modified on | 2019/01/14 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | A study on effect of salt-marinated rice malt (shio koji) on fasting blood glucose level : A randomized, double blinded, placebo controlled study | |
| Title of the study (Brief title) | A study effect of salt-marinated rice malt (shio koji)on fasting blood glucose level
|
|
| Region |
|
|
| Condition | ||
| Condition | Healthy adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate effect of salt-marinated rice malt (shio koji) on fasting blood glucose level |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Fasting blood glucose level |
| Key secondary outcomes | HOMA-R ,HbA1c |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | intake of salt-marinated rice malt (shio koji) for 12 consecutive weeks | |
| Interventions/Control_2 | intake of a placebo for 12 consecutive weeks | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Males and females from 20 to 69 years of age
(2)Fasting blood glucose level are ranged from 100 mg/dL to 125 mg/dL |
|||
| Key exclusion criteria | (1)Subjects who routinely takes foods or medicines affecting the test result
(2)Subjects who have a disease requiring regular medication or a history of serious diseases for which medication was required (3)Subjects who has under treatment or a history of serious disease (e.g., diabetes, or liver disease, kidney disease, or heart disease) (4)Heavy smoker, Heavy drinker (5)Subjects who is employed on a pre-dawn shift or on night duty more than 2 times (6)Subjects having possibilities for emerging allergy related to the study. (7)BMI is less than 18.5 or more than 30.0 (8)Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (9)Subjects who have donated over 400 mL of blood and/or blood components within the last three months prior to the current study (10)Subjects who have participated in other clinical study within the last one month prior to the current study (11)Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (12)Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating. (13)Subjects judged as unsuitable for the study by the investigator for other reasons |
|||
| Target sample size | 48 | |||
| Research contact person | |
| Name of lead principal investigator | Koike Syogo |
| Organization | MARUKOME Co.,Ltd. |
| Division name | Marketing Division Development Department |
| Address | 883 Amori Nagano-shi Nagano 380-0943 Japan |
| TEL | 026-226-0165 |
| s_koike@marukome.co.jp | |
| Public contact | |
| Name of contact person | Chiharu Goto |
| Organization | TTC Co., Ltd. |
| Division name | Clinical Research Planning Department |
| Address | 1-20-2, Ebisunishi, Shibuya-ku, Tokyo |
| TEL | 03-5459-5329 |
| Homepage URL | |
| c.goto@ttc-tokyo.co.jp | |
| Sponsor | |
| Institute | TTC Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | MARUKOME Co.,Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000032320 |